Why it's too soon to panic about COVID vaccines and the new variant
Researchers around the world are trying to work out whether existing COVID vaccines protect us from the latest variant, Omicron.
Dec 2, 2021
0
1
Researchers around the world are trying to work out whether existing COVID vaccines protect us from the latest variant, Omicron.
Dec 2, 2021
0
1
An international team of scientists believe they may have found a molecular mechanism behind the extremely rare blood clots linked to adenovirus COVID-19 vaccines.
Dec 2, 2021
1
425
A new variant named omicron (B.1.1.529) was reported by researchers in South Africa on Nov. 24, 2021, and designated a "variant of concern" by the World Health Organization two days later. Omicron is very unusual in that ...
Dec 1, 2021
2
2
What is the new variant, how is it different, and how concerned should we be?
Nov 29, 2021
0
5
The delta variant of SARS-CoV-2 has swept the planet, becoming the dominant variant within just a few months. A new study from Boston Children's Hospital, published in Science, explains why delta spreads so easily and infects ...
Nov 23, 2021
2
146
Currently available COVID vaccines require cold storage and sophisticated manufacturing capacity, which makes it difficult to produce and distribute them widely, especially in less developed countries. A new type of vaccine ...
Nov 6, 2021
5
268
Scientists at the National Institutes of Health have found that a process in cells may limit infectivity of SARS-CoV-2, and that mutations in the alpha and delta variants overcome this effect, potentially boosting the virus's ...
Nov 5, 2021
0
166
No sooner than you thought all the talk of new COVID variants was over, there's news of yet another one: AY.4.2. But what is it, where did it come from, and should we be concerned?
Oct 28, 2021
0
18
To study a virus as infectious as SARS-CoV-2, researchers need to follow laborious protocols and have access to high-biosafety laboratories. Seeking to make such investigations safer, faster, and accessible to more teams ...
Oct 14, 2021
0
104
Scientists at Lausanne University Hospital (CHUV) and EPFL have discovered a highly potent monoclonal antibody that targets the SARS-CoV-2 spike protein and is effective at neutralizing all variants of concern identified ...
Oct 12, 2021
0
1309